Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.45 EUR | +3.62% | +3.15% | -10.20% |
Mar. 14 | Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024 | CI |
Mar. 14 | Transcript : Hyloris Pharmaceuticals SA, 2023 Earnings Call, Mar 14, 2024 |
Sales 2024 * | 12.2M 13.16M | Sales 2025 * | 25.5M 27.5M | Capitalization | 321M 346M |
---|---|---|---|---|---|
Net income 2024 * | -12M -12.94M | Net income 2025 * | -4M -4.31M | EV / Sales 2024 * | 24.9 x |
Net cash position 2024 * | 16.45M 17.74M | Net cash position 2025 * | 16.2M 17.47M | EV / Sales 2025 * | 11.9 x |
P/E ratio 2024 * |
-21.8
x | P/E ratio 2025 * |
-57.3
x | Employees | 42 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 43.38% |
Latest transcript on Hyloris Pharmaceuticals SA
1 day | +3.62% | ||
1 week | -1.29% | ||
Current month | -6.53% | ||
1 month | -1.29% | ||
3 months | -11.24% | ||
6 months | -6.91% | ||
Current year | -10.20% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Jacobsen
FOU | Founder | 50 | 11-12-31 |
Stijn van Rompay
FOU | Founder | 48 | 11-12-31 |
Director of Finance/CFO | 53 | 21-09-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Carolyn Myers
BRD | Director/Board Member | 66 | 19-12-31 |
James Gale
BRD | Director/Board Member | 74 | 19-12-31 |
Leon van Rompay
BRD | Director/Board Member | 75 | 19-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 11.45 | +3.62% | 14,697 |
24-03-27 | 11.05 | -0.45% | 40,107 |
24-03-26 | 11.1 | -1.77% | 3,914 |
24-03-25 | 11.3 | +1.80% | 8,841 |
24-03-22 | 11.1 | 0.00% | 19,438 |
Real-time Euronext Bruxelles, March 28, 2024 at 12:35 pm EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.20% | 335M | |
+33.46% | 701B | |
+26.24% | 571B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 319B | |
+0.74% | 210B | |
+2.95% | 210B | |
-6.05% | 201B | |
-3.61% | 157B |